As a physician who specializes in treating myeloma, I worry that the Biden administration may soon inadvertently snuff out new therapies for myeloma and cancer in general.
I like the fact that the Inflation Reduction Act paves the way to limit copays for patients with cancer, but I worry about the long-term effects on medical innovation.